Investigation of CL26 binding on AGPAT4 protein
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://www.omicsdi.org/dataset/pride/PXD057674
下载链接
链接失效反馈官方服务：
资源简介：
We have identified CL26 as a covalent inhibitor against AGPAT4, an aberrant protein complicated in hepatocellular carcinoma (HCC). CL26 treatment reversed HCC stemness and resistance to the first-line medication sorafenib. This experiment was conducted to investigate the covalent binding of CL26 onto AGPAT4 in vitro.
创建时间：
2025-07-21
